Epistatic Role of the MYH9/APOL1 Region on Familial Hematuria Genes
Date
2013Author
Voskarides, KonstantinosDemosthenous, Panayiota
Papazachariou, Louiza
Arsali, Maria
Athanasiou, Yiannis
Zavros, Michalis
Stylianou, Konstantinos G.
Xydakis, D.
Daphnis, Eugenios K.
Gale, D. P.
Maxwell, P. H.
Elia, Avraam
Pattaro, C.
Pierides, Alkis M.
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
ISSN
1932-6203Source
PLoS ONEVolume
8Google Scholar check
Keyword(s):
Metadata
Show full item recordAbstract
Familial hematuria (FH) is explained by at least four different genes (see below). About 50% of patients develop late proteinuria and chronic kidney disease (CKD). We hypothesized that MYH9/APOL1, two closely linked genes associated with CKD, may be associated with adverse progression in FH. Our study included 102 thin basement membrane nephropathy (TBMN) patients with three known COL4A3/COL4A4 mutations (cohort A), 83 CFHR5/C3 glomerulopathy patients (cohort B) with a single CFHR5 mutation and 15 Alport syndrome patients (cohort C) with two known COL4A5 mild mutations, who were categorized as "Mild" (controls) or "Severe" (cases), based on renal manifestations. E1 and S1 MYH9 haplotypes and variant rs11089788 were analyzed for association with disease phenotype. Evidence for association with "Severe" progression in CFHR5 nephropathy was found with MYH9 variant rs11089788 and was confirmed in an independent FH cohort, D (cumulative p value = 0.001, odds ratio = 3.06, recessive model). No association was found with APOL1 gene. Quantitative Real time PCR did not reveal any functional significance for the rs11089788 risk allele. Our results derive additional evidence supporting previous reports according to which MYH9 is an important gene per se, predisposing to CKD, suggesting its usefulness as a prognostic marker for young hematuric patients. © 2013 Voskarides et al.
Collections
Cite as
Related items
Showing items related by title, author, creator and subject.
-
Article
Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion
Satra, Maria; Samara, Maria; Wozniak, Greta; Tzavara, Chara; Kontos, Angelos; Valotassiou, Varvara; Vamvakopoulos, Nikolaos K.; Tsougos, Ioannis; Aleporou-Marinou, Vassiliki; Patrinos, George P.; Kollia, Panagoula; Georgoulias, Panagiotis (2011)Aims: Coronary artery disease (CAD) is a significant cause of morbidity and mortality in modern societies. The association between genetic markers and CAD is still poorly understood. In this study, we evaluated the effect ...
-
Article
The cypriot and Iranian National Mutation Frequency Databases.
Kleanthous, Marios; Patsalis, Philippos C.; Drousiotou, Anthi; Motazacker, M.; Christodoulou, Kyproula; Cariolou, Marios A.; Baysal, E.; Khrizi, K.; Moghimi, B.; Pourfarzad, F.; van Baal, S.; Constantinou-Deltas, Constantinos D.; Najmabadi, H.; Patrinos, G. P. (2006)The National Mutation Frequency Databases are continuously updated mutation depositories, which contain extensive information over the described genetic heterogeneity of an ethnic group or population. Here, we report the ...
-
Article
The impact of human allelic variation on HIV-1 disease.
Anastassopoulou, C. G.; Kostrikis, Leontios G. (2003)Human allelic variants influence the susceptibility to HIV-1 infection and/or the subsequent rates of disease progression towards AIDS that average ten years, although they vary greatly among infected subjects. In this ...